Patent details

Herbas

VPB

Print

EN | LT

LT - ANTI-CD38 ANTIBODIES AND FUSIONS TO ATTENUATED INTERFERON ALPHA-2B

EN - ANTI-CD38 ANTIBODIES AND FUSIONS TO ATTENUATED INTERFERON ALPHA-2B

Legal status

Patent not validated

Bibliographic data

Indications of the International Patent Classification (IPC)
(51)	INT.CL.	C07K 16/28
		C07K 14/00

European patent
(11)	Number of the document	2992013
(13)	Kind of document	T
(96)	European patent application number	13721243.7
	Date of filing the European patent application	2013-04-29
(97)	Date of publication of the European application	2016-03-09
(45)	Date of publication and mention of the grant of the patent	2019-12-04
(46)	Date of publication of the claims translation

PCT application
(86)	Number	PCT/US2013/038659
	Date	2013-04-29

PCT application publication
(87)	Number	WO 2014/178820
	Date	2014-11-06

Inventors
(72)	CLARKE, Adam, AU POLLARD, Matthew, AU DOYLE, Anthony, Gerard, AT BEHRENS, Collette, AU YAMAGISHI, Tetsuo, AU WILSON, David, S. Jr., US POGUE, Sarah, L., US TAURA, Tetsuya, US

Grantee
(73)	Teva Pharmaceuticals Australia Pty Ltd, Level 2 37 Epping Road, Macquarie Park, NSW 2113, AU

Title
(54)	ANTI-CD38 ANTIBODIES AND FUSIONS TO ATTENUATED INTERFERON ALPHA-2B
	ANTI-CD38 ANTIBODIES AND FUSIONS TO ATTENUATED INTERFERON ALPHA-2B